An unusual therapy developed at The Jackson Laboratory (JAX) could change the way the world fights influenza, one of the deadliest infectious diseases. In a new study in Science Advances, researchers report that a cocktail of antibodies protected mice—including those with weakened immune systems—from nearly every strain of influenza tested, including avian and swine variants that pose pandemic threats.

Chikungunya is a vector-borne disease that affects both adults and children. While global efforts are ongoing to tackle chikungunya in adults, progress in addressing pediatric chikungunya remains inadequate. To shed light on this, researchers have investigated the presentation of pediatric chikungunya and proposed multipronged approaches to diagnose, prevent, and manage this disease. These insights may help clinicians, researchers, and policymakers to develop effective measures to tackle pediatric chikungunya.

This study found interesting, complex and important interactive effects among meteorological factors and ambient air pollutants on influenza incidences in Huaian, China.